The Future of Cancer Care: Anti-PD-1 mAbs and Next-Generation...

أضاف وظيفة جديدة Health

2026-09-21 09:25:14 -

The Future of Cancer Care: Anti-PD-1 mAbs and Next-Generation Immunotherapy

The Anti-PD-1 MAb Market is expanding as immune checkpoint inhibitors gain increasing importance in the treatment of cancer. Anti-PD-1 monoclonal antibodies (MAbs) are designed to block the programmed cell death protein 1 (PD-1) pathway, helping restore T-cell activity against cancer cells. These therapies are used across several oncology applications, either as monotherapies or in combination...

0 التعليقات 0 المشاركات 3 مشاهدة 0 معاينة